-
Control of complement-induced inflammatory responses to SARS-CoV-2 infection by anti-SARS-CoV-2 antibodies
Bermejo-Jambrina, M., van der Donk, L. E. H., van Hamme, J. L., Wilflingseder, D., de Bree, G., Prins, M., de Jong, M., Nieuwkerk, P., van Gils, M. J., Kootstra, N. A. & Geijtenbeek, T. B. H., 2 Apr 2024, In: EMBO Journal. 43, 7, p. 1135-1163 29 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Author Correction: Low energy nebulization preserves integrity of SARS-CoV-2 mRNA vaccines for respiratory delivery (Scientific Reports, (2023), 13, 1, (8851), 10.1038/s41598-023-35872-4)
van Rijn, C. J. M., Vlaming, K. E., Bem, R. A., Dekker, R. J., Poortinga, A., Breit, T., van Leeuwen, S., Ensink, W. A., van Wijnbergen, K., van Hamme, J. L., Bonn, D. & Geijtenbeek, T. B. H., 1 Dec 2023, In: Scientific reports. 13, 1, 10428.Research output: Contribution to journal › Erratum/Corrigendum › Academic › peer-review
-
SARS-CoV-2 suppresses TLR4-induced immunity by dendritic cells via C-type lectin receptor DC-SIGN
van der Donk, L. E. H., Bermejo-Jambrina, M., van Hamme, J. L., Volkers, M. M. W., van Nuenen, A. C., Kootstra, N. A. & Geijtenbeek, T. B. H., 1 Oct 2023, In: PLoS pathogens. 19, 10, e1011735.Research output: Contribution to journal › Article › Academic › peer-review
- All publications